| |
AQUAMANTYS® System - Clinical Benefits for Surgeons, Patients and Hospitals
Salient’s AQUAMANTYS® System uses patented TRANSCOLLATION® technology – a combination of RF (radiofrequency) energy and saline – to stop bleeding and reduce blood loss during surgery. Using the AQUAMANTYS generator with patented bipolar and monopolar sealers, surgeons can achieve broad tissue-surface haemostasis by applying TRANSCOLLATION technology in a painting motion, or it can be used to spot-treat bleeding vessels. The AQUAMANTYS System has been shown to offer the following benefits:
TRANSCOLLATION technology provides specific benefits in a variety of surgical procedures.
Orthopaedic Reconstruction-
Beneficial for high-risk multiple-comorbidity patients susceptible to increased blood loss ††,9
-
Reduces blood loss during total hip arthoplasty (THA) and total knee arthroplasty (TKA) procedures *,1,2
Spine
-
Successfully prevents and stops epidural bleeding near critical structures**
-
Decreases surgical time and blood loss per level fused4,10
-
May help improve visibility in the surgical field **,4
Surgical Oncology
-
Reduces need for blood transfusions during liver resections 11
-
Reduces need for renal clamping in partial nephrectomies12
-
Reduces post-operative pancreatic leaks†††,13
* Performance has not been specifically established in all procedures.
** Data established in a case study.
*** Performance has not be specifically established with the AQUAMANTYS System.
† Covance MedPar report, performance has not been specifically correlated with the AQUAMANTYS System.
†† Performance of the AQUAMANTYS System has not been specifically established in high risk multiple-comorbidity patients.
††† Performance has been demonstrated in a pre-clinical model.
View References |
